International Journal of Biological Sciences
Scope & Guideline
Fostering Innovation Across Biological Disciplines
Introduction
Aims and Scopes
- Cancer Biology and Therapeutics:
The journal emphasizes research on the molecular and cellular mechanisms of cancer, including studies on tumorigenesis, metastasis, and therapeutic interventions. - Metabolic Disorders:
Research related to metabolic syndromes, such as diabetes and obesity, and their association with cancer and other diseases is a key focus area, exploring the underlying biological pathways. - Cellular and Molecular Mechanisms:
The journal publishes studies that delve into cellular signaling pathways, gene regulation, and the role of non-coding RNAs in various biological processes. - Immunology and Inflammation:
Research on immune responses, inflammation, and their roles in disease progression, particularly in cancer and metabolic disorders, is prominently featured. - Innovative Therapeutic Strategies:
The journal encourages the exploration of novel therapeutic approaches, including drug repurposing, targeted therapies, and the use of biomaterials in clinical applications. - Extracellular Vesicles and Biomarkers:
The role of extracellular vesicles in cell communication, tumor progression, and as potential biomarkers for diseases, particularly cancer, is a significant area of interest.
Trending and Emerging
- Ferroptosis and Regulated Cell Death:
There is a rising interest in the mechanisms of ferroptosis and other forms of regulated cell death, particularly their roles in cancer and metabolic diseases. - Non-coding RNAs:
Research on non-coding RNAs, including long non-coding RNAs and microRNAs, is gaining traction as they play crucial roles in gene regulation and disease progression. - Multi-Omics Approaches:
The integration of multi-omics data (genomics, proteomics, metabolomics) to understand biological processes and disease mechanisms is increasingly emphasized. - Tumor Microenvironment Interactions:
Studies exploring the interactions between tumor cells and their microenvironment, particularly the role of immune cells and stromal components, are becoming more prominent. - Machine Learning and Bioinformatics:
The application of machine learning and bioinformatics tools for data analysis and to derive insights from complex biological datasets is on the rise. - Immunotherapy and Cancer Vaccines:
Research in immunotherapy, including the development of cancer vaccines and understanding immune evasion mechanisms, is trending as a critical area of focus.
Declining or Waning
- Basic Biological Research:
There appears to be a waning interest in purely basic biological research without direct clinical implications, as the journal increasingly prioritizes studies with clear translational potential. - Traditional Pharmacology:
Research focused on traditional pharmacological approaches is becoming less frequent, with a shift towards exploring novel mechanisms and therapies, particularly those incorporating molecular biology. - In vitro Studies:
The emphasis on in vitro studies without subsequent in vivo validation is declining, as the journal favors studies that incorporate both laboratory and clinical insights. - Animal Models in Cancer Research:
There is a noticeable decrease in the publication of studies solely based on animal models, as the emphasis shifts towards human-related studies and clinical trials. - Epidemiological Studies:
Epidemiological research, particularly those not linked with mechanistic insights or therapeutic implications, is less frequently featured in recent issues.
Similar Journals
MOLECULAR MEDICINE
Catalyzing Collaboration in Molecular ResearchMOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.
POSTEPY BIOLOGII KOMORKI
Championing Innovative Research in Cell BiologyPOSTĘPY BIOLOGII KOMÓRKI is a pivotal journal in the field of cell biology, published by the renowned Polskie Towarzystwo Anatomiczne. Since its inception, this journal has been dedicated to advancing scientific knowledge through the dissemination of high-quality research articles, reviews, and original studies focused on cellular structure and function. Although POSTĘPY BIOLOGII KOMÓRKI does not currently operate as an open-access journal, it remains a significant resource for researchers and professionals alike, contributing to critical discussions and findings in the biological sciences. The journal has undergone coverage discontinuation in Scopus, yet it continues to serve as an essential platform in Poland for scholarly exchange in cellular and anatomical research. Situated at the Centrum Medyczne Kształcenia Podyplomowego in Warsaw, it aims to bridge gaps in understanding and nurture academic growth among students and professionals in the biological sciences.
Frontiers in Bioscience-Landmark
Uncovering Landmark Research in Life SciencesFrontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.
CELLULAR AND MOLECULAR LIFE SCIENCES
Leading the Charge in Open Access Life Sciences PublishingCELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.
Cancer Cell International
Exploring New Horizons in Cancer TreatmentCancer Cell International, published by BMC, is a transformative open-access journal established in 2001, dedicated to advancing the field of oncology and cancer research. With its ISSN number not specified and an E-ISSN of 1475-2867, the journal proudly operates from the United Kingdom, located at CAMPUS, 4 Crinan St, London N1 9XW, England. Renowned for its rigorous peer-review process, Cancer Cell International has made significant strides, securing a Q2 ranking in Cancer Research and Q1 rankings in both Genetics and Oncology as of 2023. It ranks impressively in Scopus, featuring in the top quintile of Genetics (#37/347) and Oncology (#52/404), indicating its importance within the scientific community. The journal's broad scope caters to a diverse array of topics within cancer biology, making it an invaluable resource for researchers, professionals, and students seeking to stay at the forefront of cancer science. With a commitment to disseminating high-quality research, Cancer Cell International invites scholars to explore innovative findings and contribute to the collective effort of combating cancer.
Cell Death Discovery
Connecting global researchers through open-access discovery.Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.
FASEB BioAdvances
Connecting Researchers Through Open Access ScienceFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Exploring the molecular mechanisms that shape our world.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.
MOLECULAR AND CELLULAR BIOLOGY
Driving Innovation in Molecular and Cellular ScienceMOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.
FASEB JOURNAL
Innovating Knowledge in Life Sciences and BeyondFASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.